# Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)

> **NCT04436601** · PHASE4 · UNKNOWN · sponsor: **Aga Khan University** · enrollment: 102 (estimated)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DRUG:** Polyethylene Glycols
- **DRUG:** Lactulose

## Key facts

- **NCT ID:** NCT04436601
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-09
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04436601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04436601, "Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT04436601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*